The inhibitor of DNA-binding/differentiation 3 (Id3) protein is a helix-loop-helix transcription factor and may have an important role in cell proliferation and differentiation. This study was to evaluate the effects of upregulation of Id3 in human lung adenocarcinoma cells on proliferation, apoptosis, mobility and tumorigenicity. Short interference RNA suppression of Id3 (miRId3) in A549 cells was used to investigate the functional role(s) of Id3. Next, we used in vitro wound-healing assay and trans-well assay to study the effects of overexpressed Id3 on migration and invasion of A549 cells. Furthermore, to explore the influence of overexpressed Id3 on in vivo tumorigenesis, adenoviruses containing Id3 gene (Ad-Id3) and empty vector (Ad-LacZ) were generated. Co-transfection of pcDNA/ miRId3 and pEGFP/Id3 into A549 cells reversed the Id3-induced cell proliferation inhibition and apoptosis. Upon Id3 transfection, A549 cells displayed decreased migratory and invasive capabilities, however, co-transfection of miRId3 and Id3 into A549 cells reversed the Id3-induced inhibitions of migratory and invasive capabilities. Three groups of nude mice were inoculated with Ad-LacZ, Ad-Id3 transfectants and untransfected A549 cells, respectively. Twenty-eight days after inoculation, tumors induced by Ad-Id3 transfectants grew much more slowly compared with Ad-LacZ transfectants and control group. This study provides for the first time both in vitro and in vivo proofs that forced expression of Id3 in lung adenocarcinoma cells reduces tumor growth rate and may be a potential target for tumor suppression.
INTRODUCTION
The incidence and mortality rates of lung cancer have increased in recent years and lung cancer continue to be the leading cause of cancer-related death in both men and women worldwide. Approximately 70-80% of these patients were diagnosed with nonsmall cell lung cancer and the majority presented at metastatic stage. 1 Despite significant advancements have been achieved in diagnostic and therapeutic techniques, most lung cancers are still late diagnosed. It is estimated that 5-year survival rate for non-small cell lung cancer is below 18%. Therefore, the identification of strong biomarkers to develop better prognostic, diagnostic and therapeutic interventions for lung cancer is of great importance.
The inhibitor of DNA-binding/differentiation (Id) proteins are helix-loop-helix transcription factors, which lack a DNA-binding domain. Id proteins can dimerize with the key regulatory E proteins that inhibit the expression levels of multiple tumor-suppressor genes. Four Id proteins, Id1-Id4, have been described in mammals. The level of Id protein expression is correlated with tumor growth, invasiveness, metastasis, malignant potential, cell cycle regulation and angiogenesis. [2] [3] [4] [5] [6] Overexpression of Id proteins, especially Id1, have been found in different tumors, including thyroid cancer, 7 ovarian cancers 8 and colorectal cancer. 9 It has been shown that Id1 could interferes with the centrosome, which likely contributes to genomic instability and is associated with tumor aggressiveness. 10 However, the function of Id3 in tumors is not completely understood.
The Id3 gene, which was first identified as a serum-inducible immediate early gene in an established murine fibroblast cell line, 11 is involved in a variety of biological processes, 12 including lymphocyte maturation and development, [13] [14] [15] [16] vascular endothelial and smooth muscle cell differentiation 17, 18 and the development of embryonic cardiovascular cells. 19 The expression pattern and regulation mechanism of Id3 are different from those of Id1 and Id3 in different malignant tumors. Published data have suggested that Id2 is highly expressed in primary colorectal cancer, pancreatic cancer, 20 small cell lung cancer, 21 squamous cell carcinoma of the head and neck 22 and in human breast cancer lung metastases, 5 whereas Id3 expression is low in thyroid carcinoma and ovarian adenocarcinoma. 23 The Id3 gene shows a more complicated expression pattern in hepatopathy and human hepatocellular carcinoma; for instance, Id3 expression level in welldifferentiated hepatocellular carcinoma is higher compared with poorly differentiated. 24 An earlier in vitro study showed that the intracellular distributions of Id3 in human lung adenocarcinoma cells (A549), breast cancer cells (MCF7), and prostate cancer cells (PC-3M) were observed by indirect immunofluorescence assay. The results indicated that Id3 intracellular staining intensities were much higher in nuclei of PC-3M and MCF7 cells than in A549 cells. 25 Furthermore, we found that ectopic overexpression of Id3 in A549 cells could inhibit cell proliferation and induce apoptosis. 26 This study aimed to examine whether exogenous Id3 gene expression could influence other growth functions of A549 cells, including migration and invasion in vitro and tumorigenicity in vivo. The results confirmed our previous in vitro findings and proved that Id3 expression could suppress the growth of human 1 lung adenocarcinoma, which is likely due to the inhibition of cell proliferation, migration, invasion, as well as induction of apoptosis.
MATERIALS AND METHODS

Cell culture
Human lung adenocarcinoma epithelial cell A549 cell line was obtained from the American Type Culture Collection (ATCC, Manassas,VA, USA). Cells were cultured in Dulbecco's modified Eagle's medium (Hyclone, Logan, UT, USA) supplemented with 10% (v/v) fetal bovine serum (Hyclone), 100 U ml -1 of penicillin and 100 μg ml -1 of streptomycin at 37°C under a humidified 5% (v/v) CO 2 atmosphere and the medium was renewed every 2 or 3 days. Adherent cells were detached by treatment with phosphate-buffered saline, pH 7.2, 0.02% (w/v) EDTA, 0.25% (w/v) trypsin.
Plasmid construction, adenovirus generation and transfection
A recombinant eukaryotic expression vector, pEGFP/Id3 containing human Id3 was constructed as described previously. 26 pcDNA 6.2-GW/EmGFP-miR vector (Invitrogen, Grand Island, NY, USA) was used to express small interfering RNA (siRNA) targeting Id3 gene. The sense and antisense sequences of oligonucleotides encoding siRNA directed against Id3 and a negative control siRNA were as follows: Id3 sense, 5′-TGCTGTCATGTCG TCCAGCAAGCTCAGTTTTGGCCACTGACTGACTGAGCTTGGGACGACATGA-3′ and antisense, 5′-CCTGTCATGTCGTCCCAAGCTCAGTCAGTCAGTGGCCAAA ACTGAGCTTGCTGGACGACATGAC-3′ and control sense, 5′-tgctgAAATG TACTGCGCGTGGAGACGTTTTGGCCACTGACTGACGTCTCCACGCAGTACAT TT-3′ and control antisense, 5′-cctgAAATGTACTGCGTGGAGACGTCAGTCA GTGGCCAAAACGTCTCCACGCGCAGTACATTTc-3′. These sequences were compared with those in human EST database to verify that no other genes were targeted and synthesized (Invitrogen). The oligonucleotides were annealed in the sense and antisense directions to form doublestranded DNA and then cloned into the pcDNATM6.2-GW/EmGFP-miR expression vector with a BLOCK-iT Pol II miR RNAi Expression Vector Kit (Invitrogen) according to manufacturer's protocol. The recombinant expression vector (pcDNA/miRId3 and pcDNA/miRN) was identified by DNA sequence analysis.
Recombinant adenovirus vector expressing Id3 was constructed using Adenovirus Expression Vector Kit (Takara, Kyoto, Japan). Human Id3 gene was inserted into the cosmid pAxCAwtit vector to generate recombinant plasmid pAxCAwtit-Id3. pAxCAwtit-LacZ containing LacZ gene (encoding β-galactosidase) was used as empty plasmid control. Recombinant cosmids were digested by BspT104 I to generate linear recombinant adenoviral genomics, and then transfected into human embryonic kidney 293 cells (HEK293A), which provided E1 gene product necessary for viral replication. Adenovirus-expressing Id3 (Ad-Id3) or β-galactosidase (Ad-LacZ) was screened, propagated and purified from 293 cells, respectively. After large-scale preparation, the titer of each virus stock was determined by 50% tissue culture infectious dose (TCID50) method.
Reverse transcription PCR
Total RNA were isolated from cells using TRIzol Reagent (Invitrogen). In all, 1 μg sample of total RNA was reverse transcribed using the RevertAid First Strand cDNA Synthesis Kit (Fermentas, Vilnius, Lithuania, EU). PCR was done with 25 μl of reaction mixture containing 12.5 μl of Premix Ex Tag loading dye mix (Takara), 7.5 μl of double-distilled water, 1.5 μl of forward primer (5′-ATGAAGGCGCTGAGCCCGGT-3′), 1.5 μl of reverse primer (5′-TTT GCCACTCGGCCGT-3′) and 2 μl of template. The complementary DNA was amplified under the following reaction conditions: 94°C for 5 min then 35 amplification cycles of 94°C for 50 s, 55°C for 50 s, 70°C for 50 s and 72°C for 5 min. As internal control, glyceraldehyde 3-phosphate dehydrogenase (5′-CAACTACATGGTTTACATGTTC-3′, 5′-GCCAGTGGACTCACGAC-3′) was amplified simultaneously. Amplification products were detected by 1.5% (w/v) agarose gel electrophoresis. Three independent experiments were performed. Student's t-test was used when comparing A549 cells transfected with pEGFP/Id3 or pEGFP groups. The differences between scramble groups pEGFP/Id3, pEGFP and control were significant (Po0.05).
Annexin V/7-aminoactinomycin staining and flow cytometry Cell apoptosis was quantified using Annexin V/7-aminoactinomycin staining followed by flow cytometry. A549 cells were cultured on six-well plates to 90% confluent density, transfected for 24 h, collected by trypsinization, washed twice with phosphate-buffered saline then suspended in 100 μl of binding buffer containing 10 mM HEPES/NaOH (pH 7.4), 140 mM NaCl and 2.5 mM CaCl 2 (BD Biosciences, Franklin Lakes, NJ, USA). Cells were incubated with Annexin V-PE (BD Biosciences Pharmingen), a marker of early phase apoptosis, and with 7-aminoactinomycin (BD Biosciences Pharmingen), an indicator of late apoptosis, and then analyzed on a FACSCalibur flow cytometer (BD Biosciences).
Proliferation assay
The effect of Id3 expression on cell proliferation was measured using the colorimetric MTT Assay Kit (Sigma, St Louis, MO, USA). The Id3 transfectant, Id3 siRNA transfectant and control transfectant lines were cultured in 96well plates with Dulbecco's modified Eagle's medium and MTT assay was applied according to the manufacturer's instructions. The absorbance was measured at 570 nm by the Multiskan MS microplate reader (Labsystems, VersaMax, Molecular Devices, Sunnyvale, CA, USA) with a blank reference at 650 nm. The cell viability was calculated according to the formula: cell viability (%) = average A570 nm of treated group/average A570 nm of control group × 100%. Each experiment was performed in quadruplicate and repeated at least three times.
Cell migration assay
Cell migration in vitro was determined by the wound-healing migration assay. Briefly, A549 cells were seeded on six-well culture plates and cultured in Dulbecco's modified Eagle's medium containing 10% (v/v) fetal bovine serum to 90% confluence. At 36 h after Id3 transfection, cell monolayer was scratched with a sterile pipet tip. The monolayer was washed twice with phosphate-buffered saline, pH 7.2 to remove floating cells and 2 ml of serum-free medium was added to each well. Migration of cells toward the 'wound' was recorded by taking pictures under a microscope (Olympus, Tokyo, Honshu, Japan) at a magnification of × 100 at 0 h and 36 h after cell monolayer was scratched. Each experiment was performed in triplicates and repeated at least three times under independent culture conditions.
Cell invasion assay
Cell invasion was assayed using a Boyden chamber with a culture chamber insert system (NUNC, Grand Island, NY, USA) with an 8-μm porous membrane bottom for 12-well plates. The membrane of the upper chamber was coated with 300 μg ml -1 Matrigel (BD Biosciences). At 20 h after transfection, cells (1 × 10 5 per well) were harvested using 0.25% trypsin and plated in the upper chamber in 700 μl of serum-free medium and the lower chamber was filled with 1500 μl of Dulbecco's modified Eagle's medium containing 10% (v/v) fetal bovine serum as a chemoattractant. After 30 h of incubation at 37°C, cells on the upper surface of the filter were removed with a cotton swab. The cells that had invaded the Matrigel and migrated into the inverse surface of the membrane were fixed with 4% (v/v) paraformaldehyde for 30 min, stained with hematoxylin and eosin for 10 min, then observed under a light microscope at × 200 magnification. Cells migrated to the bottom side were counted in five different fields to obtain average number per cell group. Each experiment was performed in triplicates and repeated at least three times under independent culture conditions.
Tumor xenografts in nude mice
For in vivo studies, A549 cells were infected with prepared Ad-Id3 and Ad-LacZ. Fifteen nude mice (BALB/c nu/nu; 5-week-old females; Medical Center of Experimental Animals, Jinling Hospital) were used and divided into three groups. Ad-Id3-transfected cells (2 × 10 6 cells per mouse), Ad-LacZ-transfected cells (2 × 10 6 cells per mouse) and untransfected A549 cells (2 × 10 6 cells per mouse) were injected subcutaneously into the right flank of each mouse. After the xenograft models of A549 lung adenocarcinoma were constructed, we compared the xenografts' growth differences among the three groups. The tumors of nude mice subcutaneous tissue were observed every 7 days. The tumor volume was measured with caliper 1 month after the initial subcutaneous injection, using the formula: V = 1/2 × length × (width) 2 where L is length (mm) and W is width(mm). At 4 weeks after inoculation, mice were killed and the xenografts were resected, fixed and determined for the expression of Id3 gene and protein with reverse transcriptase-PCR and immunohistochemistry techniques. Three repeated tests were performed for each set of measurements and the resulting data were averaged. Animal experiments were approved by the Animal Care and Use Committee of our hospital and were conducted in compliance with Institutional guidelines.
Immunohistochemistry
Immunohistochemistry was done with Bouin-fixed, paraffin-embedded sections (4-μm thick) obtained from tumors in nude mice. Tissue sections were deparaffinized and incubated in 3% (v/v) H 2 O 2 for 10 min to quench endogenous peroxidase activity. Nonspecific reactivity was blocked by incubating the samples in 5% (v/v) goat serum (diluted with phosphatebuffered saline (pH 7.2)) overnight at 4°C after the tissue sections were boiled in a microwave for 5 min to retrieve cell antigens. Tumor sections were probed with a mouse monoclonal anti-hId3 antibody (1:200 dilution; Abcam, HKSP, Shatin, NT, Hong Kong). The Id3 antigen-antibody complexes were detected by avidin/biotin/peroxidase method and all sections were counterstained with hematoxylin, dehydrated in a graded ethanol series and then coverslips were placed on top with a mounting medium.
Statistical analysis
All data were presented as means ± s.d. with at least three independent experiments, each performed at least in triplicate. One-way analysis of variance was used to determine the statistical significance between different groups. Means were compared using Student's t-tests, and Po0.05 was accepted as statistically significant. All data were analyzed with SPSS 13.0 software (Chicago, IL, USA).
RESULTS
Effects of siRNA targeting Id3 on proliferation and apoptosis of A549 cells
In order to further verify the in vitro anti-proliferative and proapoptotic roles of ectopic expression of Id3 in A549 cells, 26 we used RNA interfering technique to suppress exogenous Id3 expression in A549 cells and found that the effects caused by overexpressed Id3 could be reverted. The MTT results showed that proliferation was inhibited significantly in pEGFP/Id3-transfected A549 cells; inhibitory rate was 61.2% as compared with that of control transfectant (11.2%). The inhibitory rate of A549 cells cotransfected with pEGFP/Id3 and pcDNA/miRId3, however, was reduced to 8.3% compared with the parental cells in the MTT assay (Figure 1a ). Consistent with cell proliferation assay results, the (Figures 1b and c) . Taken together, these results indicated that exogenous Id3 expression in A549 cells could inhibit cell proliferation and induce apoptosis. Co-transfection of pcDNA/miRId3 and pEGFP/Id3 into A549 cells could reverse the Id3-induced proliferation inhibition and apoptosis.
Effects of Id3 expression on cell migration and invasion of A549 cells
To investigate the migratory capability of Id3 overexpressed A549 cells, wound-healing assay was utilized. As shown in Figure 2a , after 36 h of cell monolayer scratched, fewer Id3/EGFP-transfected A549 cells had migrated to the denuded zone compared with pEGFP-transfected and control cells. Id3-expressing A549 cells exhibited a statistically significant reduction (64.1-66.7%) in migratory activity compared with the pEGFP-transfected and control A549 cells (Po 0.01; Figure 2a and b).
After cells were co-transfected with miRId3 and Id3, no significant reduction of cell migratory activities were found (P o 0.01; Figures 2c and d) .
The impact of Id3 transfection on tumor cell invasion was confirmed by staining cells invaded through Matrigel-coated membranes after removal of non-invaded cells from the upper surface of the trans-well membrane. The invasive cells (mean ± s.d.) from five different areas were counted and photographed under the microscope (magnification × 200). Id3-transfected clones showed a drastic reduction (78-87%) with respect to the control clones (Figure 3a) . The mean invasion index of cells transfected with Id3 gene was 57.0 ± 9.9, whereas the mean was 83.7 ± 19.1 and 88.0 ± 14.8 in the pEGFP group and the control group (P o0.05; Figure 3a and b), respectively. Next, A549 cells were co-transfected with miRId3 or miRN and Id3. The results showed that miRN and Id3-co-transfected group had an significant decreased invasive capabilities (72-79%) compared with control group and miRId3-mediated group. The mean invasion index of cells co-transfected with miRN and Id3 was 55.4 ± 12.1, whereas the mean was 86.2 ± 11.4 and 80.4 ± 13.6 in the control group and miRId3-mediated group (Po 0.05; Figure 3c and d), respectively. These results suggested the Id3 gene prominently inhibited the migratory and invasive capabilities of A549 cells.
Effect of Id3 expression on in vivo tumorigenesis
To examine whether the in vitro inhibitory roles of Id3 overexpression in A549 cell proliferation, invasion and migration exhibited the similar effects on tumor growth in vivo, tumorigenicity assays were performed using subcutaneous injection of Id3-transfected A549 cells into nude mice. Three groups of nude mice were inoculated with Ad-LacZ, Ad-Id3 transfectants and control A549 cells, respectively, and tumorigenicity of these differently treated A549 cells was evaluated by measuring the tumor volume after 28 days of inoculation. Nodular tumors were observed on each mouse with different size. As shown in Figure 4a , tumors produced by Ad-Id3 transfectants grew much more slowly compared with Ad-LacZ transfectants and control group. A vernier caliper was used to measure the size of each xenografted tumor; the volume (mean ± s.d.) of tumors in mice injected with Ad-Id3 transfectants was 2.22 ± 0.70 mm 3 , which was notably smaller compared with Ad-LacZ group (85.78 ± 59.70mm 3 ) and control group (142.18 ± 54.52 mm 3 ) (Figure 4b ).
After 28 days of inoculation, all mice were killed and tumors were resected. Total RNA were extracted and reversely transcribed to complementary DNA, and then Id3 mRNA was detected using reverse transcriptase-PCR with Id3-specific primer pairs. The expression level of Id3 mRNA in Ad-Id3-transfected tumor cells was significantly higher than in the other two groups (Figure 4c ). We also examined the expression of Id3 protein in tumor tissues by immunohistochemistry. Tumor biopsies were stained with Id3 antibody and Id3 expression was localized mainly in the nucleus of cells in the Ad-Id3-transfected tumors and in the cytoplasm in a few of these cells. In contrast, there was a low level of Id3 protein expression in tumor cells of Ad-LacZ group (Figure 4d) . These results showed that Id3 could suppress growth of lung adenocarcinoma cells in vivo.
DISCUSSION
A growing body of evidences point that Id3 gene has multiple roles in cell cycle regulation. When cells from different sources received diverse stimulation, they were able to regulate Id3 expression through different mechanisms and signal transduction pathways; therefore, Id3 gene exhibited cell type and developmental stage specificity. Although there are numberous information about the role of Id3 in other cancer types, 27, 28 little was known about its involvement in lung adenocarcinoma.
In this study, we aimed to prove whether Id3 affects A549 cell proliferation and apoptosis. Different from many other tumor types, 28, 29 a series of assays showed that transgene expression of Id3 protein could be attributed to suppressing growth and promoting apoptosis of A549 cells. 26 To further confirm previous results, gain-and loss-of-function studies of Id3 were performed using pEGFP-mediated overexpressed Id3 and siRNA-mediated knockdown Id3, respectively. We transiently transfected Id3expressing vector, pEGFP/Id3 and siRNA vector targeting Id3, pcDNA/miRId3 alone or together into A549 cells. As shown by the results of MTT and Annexin V-PE/7-ADD-staining assays, the exogenous Id3 expression induced A549 cells growth inhibition and apoptosis, and these effects would be rescued by cotransfection of pEGFP/Id3 with pcDNA/miRId3, which indicated the effects of Id3 on growth inhibition and apoptosis promotion was specific. Interestingly, this study showed that the endogenous Id3 mRNA could be effectively suppressed by transfection with pcDNA/miRId3 alone (data not shown), but no significant effects were observed on cell growth and apoptosis. This may be caused by low expression level of Id3 in A549 cells and unconspicuous transfection effect of siRNA targeting Id3.
As we all know, strategies to inhibit the growth and invasion of tumor cells have great potentialities throughout the treatment of metastatic cancers. There was a great difference in the expression and function pattern between Id3 and other Id genes in human lung adenocarcinoma, and the Id3 protein exhibited different mechanism from other Id proteins known to stimulate cell proliferation and inhibit cell differentiation. To test the hypothesis, exogenous Id3 gene was transfected into A549 cells and the consequent functional changes were evaluated in vitro and in vivo. By elevating Id3 expression, we were able to demonstrate that it decreased migration rate in A549 cell line utilizing wound-healing assay. We also confirmed that modified Id3 expression could modulate invasion through basement membrane substrata and matrigel by A549 cells via Boyden chamber assay. Meanwhile, the combination of miRId3 and Id3 also support the biological role of Id3. Matrigel was composed of laminins and type IV collagen to mimic the in vivo extracellular matrix. The cells must secrete some enzymes such as matrix metalloproteinases to degrade matrigel and crawl through the membrane to the lower chamber. Results of wound-healing and Boyden chamber assays together suggested that exogenous Id3 expression had significant roles in the metastasis of A549 cells. To examine whether the in vitro inhibitory roles of Id3 overexpression in A549 cell proliferation, invasion and migration exhibited the similar effects on tumor growth in vivo, we inoculated Ad-Id3 and adenovirus containing LacZ (Ad-LacZ) transfected A549 cells into nude mice. There was a significant reduction in the total volume of tumor nodules produced by Ad-Id3 transfectants compared with control transfectants. The in vivo study results were in accord with those of in vitro study, which revealed that overexpressed Id3 protein could inhibit A549 cell proliferation, increase cell apoptosis, suppress cell migration and invasion, and inhibit tumorigenicity significantly in nude mouse.
Some studies have shown that Id3 may have a key role in lymphocyte survival. The response of lymphocyte progenitors to transforming growth factor β would be disturbed in the absence of Id3, and integration of Id3 into B lymphocyte progenitors leads to retardation of B lymphocyte progenitors growth and apoptosis, which is similar to transforming growth factor β function. 30 Furthermore, exogenous Id3 expression arrests the cell cycle in G1 phase, thereby suppressing WEHI-231 cell growth by simulating BCR ligand-forming activity. 31 Simbulan-Rosenthal et al. 32 found that Id3 expression in keratinocytes was upregulated when exposing to ultraviolet B radiation, which induced apoptosis.
Further studies showed that presence of reactive oxygen species was the cause of upregulation of Id3 through exposure to UV radiation. 33 Moreover, transfection of Id3-recombinant adenovirus could induce apoptosis in HaCaT cells and enhance the sensitivity of X-ray-induced apoptosis in HaCaT cells. 34 In contrast, the study showed that DMH2, a small molecule antagonist of the BMP type I receptors, effectively decreases Id1 and Id3 expression and suppresses growth of cancer cells expressing Oct4 or Nestin. 35 Furthermore, Chen et al. 36 found that suppression of Id3 expression in small cell lung carcinoma cells produced significant reductions in proliferation rates and in numbers of colonies formed in soft agar assay. We speculated that Id3 was regulated by complex mechanisms in tumor cells. The association between Id3 and the severity of tumor have not been consistently concluded. Recently, a study demonstrated that the tumor co-expression of Id1 and Id3 can be a powerful prognostic biomarker in a selected subgroup of stage III-N2 NSCLC patients receiving definitive chemoradiotherapy. Interestingly, the study also found that Id1 and Id3 co-expression seems associated with poor clinical outcomes in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy. 37 We suppose that it could be of theoretical interest to know what is the extent of such functional overlapping and compensation of Id1 and Id3 genes in human lung cancer cell line A549.
In summary, there were few reports in the literature on direct effects of upregulation of Id3 gene on human lung adenocarcinoma cells. This study provided for the first time both in vitro and in vivo proofs that forced expression of Id3 in lung adenocarcinoma cells reduced tumor growth rate, which was associated with decreased cell proliferation, migration, invasion and increased apoptosis. The results of this study suggested that high levels of Id3 protein were correlated with a moderate response of human lung adenocarcinoma and that it may be a potential target for lung cancer suppression. Targeting may have important clinical implications and upregulated Id3 expression could be of great help in combating drug-resistant lung adenocarcinoma. Further investigations are still needed to determine the mechanisms and pathways through which Id3 affects biological activity in human lung adenocarcinoma epithelial cells.
